Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0039 | 0.1267 | 0.3273 |
Trypanosoma brucei | cyclophilin a | 0.0071 | 0.297 | 1 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0039 | 0.1267 | 0.5 |
Toxoplasma gondii | exonuclease III APE | 0.0039 | 0.1267 | 0.3273 |
Echinococcus multilocularis | expressed protein | 0.0071 | 0.297 | 0.1951 |
Toxoplasma gondii | cyclophilin precursor | 0.0071 | 0.297 | 1 |
Trichomonas vaginalis | peptidyl-prolyl cis-trans isomerase A, ppia, putative | 0.0071 | 0.297 | 1 |
Brugia malayi | hypothetical protein | 0.0023 | 0.0437 | 0.1473 |
Trypanosoma brucei | peptidyl-prolyl cis-trans isomerase, putative | 0.0071 | 0.297 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0046 | 0.1627 | 0.0413 |
Plasmodium vivax | cyclophilin, putative | 0.0071 | 0.297 | 1 |
Leishmania major | cyclophilin 4, putative | 0.0071 | 0.297 | 1 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0039 | 0.1267 | 0.3273 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0039 | 0.1267 | 0.3273 |
Schistosoma mansoni | cyclophilin | 0.0071 | 0.297 | 0.1951 |
Trypanosoma cruzi | 21 kDa cyclophilin, putative | 0.0071 | 0.297 | 1 |
Loa Loa (eye worm) | cyclophilin Ovcyp-2 | 0.0071 | 0.297 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0039 | 0.1267 | 0.5 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0039 | 0.1267 | 0.3273 |
Trypanosoma cruzi | cyclophilin, putative | 0.0071 | 0.297 | 1 |
Leishmania major | cyclophilin a | 0.0071 | 0.297 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.1627 | 0.0413 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0046 | 0.1627 | 0.0413 |
Leishmania major | cyclophilin 11, putative | 0.0071 | 0.297 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0039 | 0.1267 | 0.3273 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0046 | 0.1627 | 0.0413 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 1 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0046 | 0.1627 | 0.4697 |
Onchocerca volvulus | 0.0071 | 0.297 | 0.5 | |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0039 | 0.1267 | 0.5 |
Toxoplasma gondii | cyclophilin 1, putative | 0.0071 | 0.297 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0039 | 0.1267 | 0.3273 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0039 | 0.1267 | 0.4264 |
Trypanosoma cruzi | peptidyl-prolyl cis-trans isomerase, putative | 0.0071 | 0.297 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 1 | 1 |
Trypanosoma brucei | cyclophilin, putative | 0.0071 | 0.297 | 1 |
Trypanosoma brucei | peptidyl-prolyl cis-trans isomerase, putative | 0.0071 | 0.297 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0046 | 0.1627 | 0.5478 |
Brugia malayi | cyclophilin-type peptidyl-prolyl cis-trans isomerase-2, Bmcyp-2 | 0.0071 | 0.297 | 1 |
Echinococcus granulosus | expressed protein | 0.0071 | 0.297 | 0.1951 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.1627 | 0.0413 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0039 | 0.1267 | 0.5 |
Trypanosoma cruzi | cyclophilin type peptidyl-prolyl cis-trans isomerase | 0.0071 | 0.297 | 1 |
Brugia malayi | cyclophilin-type peptidyl-prolyl cis-trans isomerase-3, Bmcyp-3 | 0.0071 | 0.297 | 1 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0039 | 0.1267 | 0.5 |
Trypanosoma cruzi | rotamase, putative | 0.0071 | 0.297 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0039 | 0.1267 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0046 | 0.1627 | 0.0413 |
Plasmodium falciparum | peptidyl-prolyl cis-trans isomerase | 0.0071 | 0.297 | 1 |
Plasmodium vivax | unspecified product | 0.0071 | 0.297 | 1 |
Loa Loa (eye worm) | cyclophilin-type peptidyl-prolyl cis-trans isomerase-2 | 0.0071 | 0.297 | 1 |
Onchocerca volvulus | 0.0071 | 0.297 | 0.5 | |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.1627 | 0.0413 |
Echinococcus multilocularis | geminin | 0.0205 | 1 | 1 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0039 | 0.1267 | 0.3273 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.4611 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540262] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.